The Role of Social Contacts and Original Antigenic Sin in Shaping the Age Pattern of Immunity to Seasonal Influenza

PLoS Computational Biology

Volumn 8, Issue 10, 2012, Pages

  Kucharski, Adam J ^a   Gog, Julia R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS;

ANTIGENICS; CANDIDATE MECHANISMS; DIFFERENT AGES; DISEASE DYNAMICS; EMPIRICAL STUDIES; IMMUNE RESPONSE; INFLUENZA A; OLD AGE; SOCIAL CONTACTS;

MIXING;

EID: 84868115483     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1002741     Document Type: Article

References (45)

1. Wilson I, Cox N, (1990) Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8: 737-787.
2. Gilbert GL, Cretikos MA, Hueston L, Doukas G, O'Toole B, et al. (2010) Influenza a (h1n1) 2009 antibodies in residents of new south wales, australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS One 5: e12562.
3. Ikonen N, et al. (2010) High frequency of cross-reacting antibodies against 2009 pandemic influenza a(h1n1) virus among the elderly in finland. Eurosurveillance 15.
4. Johnson BF, Wilson LE, Ellis J, Elliot AJ, Barclay WS, et al. (2009) Fatal cases of influenza a in childhood. PLoS One 4: e7671.
5. Mak GC, Choy PWW, Lee WY, Wong AH, Ng KC, et al. (2010) Sero-immunity and serologic response to pandemic influenza a (h1n1) 2009 virus in hong kong. J Med Virol 82: 1809-15.
6. Skowronski DM, Hottes TS, McElhaney JE, Janjua NZ, Sabaiduc S, et al. (2011) Immunoepidemiologic correlates of pandemic h1n1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age. J Infect Dis 203: 158-67.
7. Tandale B, Pawar S, Gurav Y, Chadha M, Koratkar S, et al. (2010) Seroepidemiology of pandemic influenza A(H1N1) 2009 virus infections in pune, india. BMC Infect Dis 10: 255.
8. Zimmer SM, Crevar CJ, Carter DM, Stark JH, Giles BM, et al. (2010) Seroprevalence following the second wave of pandemic 2009 h1n1 influenza in pittsburgh, pa, usa. PLoS One 5: e11601.
9. Grenfell B, Anderson R, (1985) The estimation of age-related rates of infection from case notifications and serological data. Epidemiol Infect 95: 419-436.
10. Anderson R, May R, (1985) Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes. J Hyg (Camb) 94: 365-436.
11. Melegaro A, Jit M, Gay N, Zagheni E, Edmunds WJ, (2011) What types of contacts are important for the spread of infections?: using contact survey data to explore European mixing patterns. Epidemics 3: 143-51.
12. Conlan AJK, Eames KTD, Gage JA, von Kirchbach JC, Ross JV, et al. (2011) Measuring social networks in british primary schools through scientific engagement. Proc Biol Sci 278: 1467-75.
13. Mossong J, Hens N, Jit M, Beutels P, Auranen K, et al. (2008) Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 5: e74.
14. Kucharski AJ, Gog JR, (2012) Age profile of immunity to influenza: effect of original antigenic sin. Theor Popul Biol 81: 102-112.
15. Francis T Jr, (1960) On the doctrine of original antigenic sin. Proc Am Philos Soc 104: 572-578.
16. Hobson D, Curry R, Beare A, Ward-Gardner A, (1972) The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza a2 and b viruses. J Hyg (Lond) 70: 767-777.
17. Potter CW, (1979) Determinants of immunity to influenza infection in man. Br Med Bull 35: 69-75.
18. Andreasen V, (2003) Dynamics of annual influenza a epidemics with immuno-selection. J Math Biol 46: 504-536.
19. Boni MF, (2008) Vaccination and antigenic drift in influenza. Vaccine 26S: C8-C14.
20. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, et al. (2008) The genomic and epidemiological dynamics of human influenza a virus. Nature 453: 615-619.
21. Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, et al. (2008) The global circulation of seasonal influenza a (h3n2) viruses. Science 320: 340-46.
22. Lavenu A, Leruez-Ville M, Chaix M, Boelle P, Rogez S, et al. (2005) Detailed analysis of the genetic evolution of influenza virus during the course of an epidemic. Epidemiol Infect 134: 514-520.
23. Nelson MI, Edelman L, Spiro DJ, Boyne AR, Bera J, et al. (2008) Molecular epidemiology of a/h3n2 and a/h1n1 influenza virus during a single epidemic season in the united states. PLoS Pathog 4: e1000133.
24. Smith DJ, Lapedes AS, de Jong JC, Besterbroer TM, Rimmelzwaan GF, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305: 371-376.
25. Anker M, Schaaf D, (2000) Who report on global surveillance of epidemic-prone infectious diseases. World Health Organisation.
26. World Health Organisation (2009) Recommended composition of influenza virus vaccines. Wkly Epidemiol Rec.
27. Andreasen V, (2011) The final size of an epidemic and its relation to the basic reproduction number. Bull Math Biol 73: 2305-21.
28. Australian Bureau of Statistics (2010) Population by age and sex, australian states and territories. Australian Demographic Statistics (cat no 31010) Available from: http://abs.gov.au.
29. Official Statistics of Finland (2010) Population structure [e-publication] ISSN = 1797- 5395. Helsinki: Statistics Finland Access method: http://www.stat.fi.
30. Blank P, Schwenkglenks M, Szucs T, (2009) Vaccination coverage rates in eleven european countries during two consecutive influenza seasons. J Infect 58: 446-458.
31. Gill TK, Taylor AW, Watson M, (2007) Trends in influenza immunisation amongst an elderly australian community. Vaccine 25: 5428-32.
32. Gilks W, Richardson S, Spiegelhalter D (1996) Markov chain Monte Carlo in practice. Boca Raton, FL: Chapman & Hall/CRC.
33. Burnham K, Anderson D (2002) Model selection and multimodel inference: a practical information-theoretic approach. Second edition. New York: Springer-Verlag.
34. Chowell G, Miller MA, Viboud C, (2008) Seasonal influenza in the united states, france, and australia: transmission and prospects for control. Epidemiol Infect 136: 852-864.
35. Gran JM, Iversen B, Hungnes O, Aalen OO, (2010) Estimating influenza-related excess mortality and reproduction numbers for seasonal influenza in norway, 1975-2004. Epidemiol Infect 138: 1559-68.
36. Grund S, Adams O, Wählisch S, Schweiger B, (2011) Comparison of hemagglutination inhibition assay, an elisa-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza a h1n1 2009 virus. J Virol Methods 171: 369-73.
37. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, et al. (2010) Incidence of 2009 pandemic influenza a h1n1 infection in england: a cross-sectional serological study. Lancet 375: 1100-8.
38. Kim J, Skountzou I, Compans R, Jacob J, (2009) Original antigenic sin responses to influenza viruses. Journal Immunol 183: 3294.
39. Lambert PH, Liu M, Siegrist CA, (2005) Can successful vaccines teach us how to induce efficient protective immune responses? Nat Med 11: S54-62.
40. Lessler J, Riley S, Read JM, Wang S, Zhu H, et al. (2012) Evidence for antigenic seniority in influenza a (h3n2) antibody responses in southern china. PLoS Pathog 8: e1002802.
41. Vu T, Farish S, Jenkins M, Kelly H, (2002) A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 20: 1831-6.
42. Goodwin K, Viboud C, Simonsen L, (2006) Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24: 1159-69.
43. Lessler J, Cummings DAT, Read JM, Wang S, Zhu H, et al. (2011) Location-specific patterns of exposure to recent pre-pandemic strains of influenza a in southern china. Nat Commun 2: 423.
44. Truscott J, Fraser C, Cauchemez S, Meeyai A, Hinsley W, et al. (2011) Essential epidemiological mechanisms underpinning the transmission dynamics of seasonal influenza. J R Soc Interface 9: 304-312.
45. Reichert T, Chowell G, Nishiura H, Christensen R, McCullers J, (2010) Does glycosylation as a modifier of original antigenic sin explain the case age distribution and unusual toxicity in pandemic novel h1n1 influenza? BMC Infect Dis 10: 5.